Rxwire
In the news · 48h FDA 37 Eli Lilly 17 Roche 9 Merck & Co. (MSD) 7 Johnson & Johnson 4 AstraZeneca 3 Novo Nordisk 3 AbbVie 2
Approvals & regulatory · first seen 10h ago, updated 7h ago

Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalry

2 outlets Eli Lilly FDA

The weekly insulin Onswik will now be available to U.S. patients after initial approvals in Europe, Mexico and Japan.

Summary from BioSpace - All News.

Coverage 2 articles · 2 outlets

  1. BioSpace - All News
    Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalry
  2. Endpoints News
    FDA approves Eli Lilly's once-weekly insulin pen, setting up rivalry with Novo